Lack of an association between the aPKCλ/ι expression in prostate cancer and the patient outcomes

Int J Surg Case Rep. 2017:37:180-182. doi: 10.1016/j.ijscr.2017.06.047. Epub 2017 Jun 29.

Abstract

  1. This is the first study to assess aPKCλ/ι expression in primary prostate cancer with metastatic disease.

  2. A total of 43 patients with prostate cancer and its metastasis to the lymph node and/or bone were analyzed in this study.

  3. We found no strong association between aPKCλ/ι expression and the prognosis of the patients.

Keywords: Hormonal therapy; Prostate cancer; aPKC.